GlassScriptPhysician profile
Dennis M Bell
NPI 1780612473
$3,789.08
in general payments reported to CMS, 2019-2025
34 companies · $549 in 2025
The $549 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $84.91 · 2021: $293 · 2022: $743 · 2023: $831 · 2024: $851 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $611.73 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $400.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $391.49 | 2023-2025 | |
| Abbott Laboratories | $384.70 | 2019-2025 | Freestyle Libre 3, Eterna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.80 | 2019-2024 | Jardiance |
| Exact Sciences Corporation | $227.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $214.00 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $180.16 | 2019-2025 | Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $106.92 | 2019-2025 | Breztri, Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $104.66 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $90.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $89.70 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $89.26 | 2019-2024 | Dificid, Vaqta, Gardasil |
| Astellas Pharma US INC | $81.76 | 2019-2025 | Veozah |
| Idorsia Pharmaceuticals US INC | $76.67 | 2022-2023 | Quviviq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $49.39 | 2023 | Xarelto |
| Dexcom, INC. | $48.30 | 2023-2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $39.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.06 | 2022 | |
| Medtronic, INC. | $31.55 | 2023-2024 | Venaseal |
| Genentech USA, INC. | $28.56 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $26.30 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.79 | 2021 | |
| Jazz Pharmaceuticals INC. | $24.07 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $23.45 | 2019-2021 | |
| Sobi, INC | $23.16 | 2021 | |
| Dynavax Technologies Corporation | $21.06 | 2023 | Heplisav-B |
| Alk-Abello, INC | $17.76 | 2025 | Neffy, Grastek, Odactra |
| Biohaven Pharmaceuticals, INC. | $16.97 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.83 | 2023 | Eliquis |
| Adlon Therapeutics L.P. | $14.12 | 2019 | |
| Allergan, INC. | $13.39 | 2019 | |
| Amgen INC. | $12.03 | 2019 | |
| Ironwood Pharmaceuticals, INC | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.